Clinical Trial Update: An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus [Phase 4]

View source ↗

Summary

This update describes a Phase 4 trial evaluating Cisapride for improving gastroparesis symptoms in patients with diabetes, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• Cisapride (cisapride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Gastroparesis, Diabetes Mellitus | Phase 4 | Status: TERMINATED